Assignee
SIRNAOMICS INC
US·7 granted patents·36 pending applications·28 citations·filing 2008–2025
Top patents by PatentIndex Score
43 records- 0193US11058779B2Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infectionSIRNAOMICS INC·Filed 2016·Granted Jul 13, 2021·18 cites·20 claims
- 0287US12006500B2Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)SIRNAOMICS INC·Filed 2021·Granted Jun 11, 2024·2 cites·16 claims
- 0385US12054714B2Peptide docking vehicle for targeted nucleic acid deliverySIRNAOMICS INC·Filed 2020·Granted Aug 6, 2024·1 cites·13 claims
- 0484USRE46873EMulti-targeted RNAi therapeutics for scarless wound healing of skinSIRNAOMICS INC·Filed 2008·Granted May 29, 2018·5 cites·21 claims
- 0581US11697813B2Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosisSIRNAOMICS INC·Filed 2017·Granted Jul 11, 2023·2 cites·11 claims
- 0674US2025313837A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0773US2025313846A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0870US2025249027A1Products and compositionsSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 0969US12378552B2Oligomeric compound for inhibiting expression of factor XISIRNAOMICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·20 claims
- 1069US2025027086A1COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS USING MODIFIED siRNA-GEM AGENTSSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 1168US2023365969A1Methods for inducing adipose tissue remodeling using rnai therapeuticsSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1268US2024158794A1NUCLEOSIDE CONTAINING siRNAS FOR TREATING VIRAL DISEASESSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1367US2024175032A1Compositions and methods for inhibiting expression of pcsk9SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1467US2023257753A1Products and compositionsSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1567US2023392154A1Targeted nucleic acid therapy for hepatitis bSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1665US2023355656A1Compositions and methods for treatment of skin cancersSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1764US2024108741A1COMBINATION siRNA AND PEPTIDE DOCKING VEHICLE (PDoV) COMPOSITIONS AND METHODS OF THEIR USE FOR IMPROVED REGULATION AND FUNCTIONALITYSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 1863US2023250432A1siRNA-Copolymer Compositions And Methods Of Use For Treatment Of Liver CancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 1962US2023323358A1COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCERSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 2062US2022282258A1CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCERSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2161US2022145301A1siRNA/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral InfectionSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2261US2023089502A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2361US2022411802A1METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST NSD3SIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2461US2023089915A1Products and compositionsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2560US2022331441A1Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2659US2021324384A1SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCERSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2759US2022387599A1Oligonucleotides with nucleoside analogsSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 2858US2021332358A1MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOFSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 2958US2024110187A1METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-ProteinSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 3057US2022288228A1METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST BCLXL AND MCL1 USING A POLYPEPTIDE NANOPARTICLESIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3156US2021371861A1Multi-Targeting Nucleic Acid Constructs Composed Of Multiple Oligonucleotides That Modulate Gene Expression Through Complimentary Interactions With TargetsSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 3256US2025263704A1Nucleic acid-polypeptide nano-pharmaceutical compostion for treating and preventing human papilloma virus infectionSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3356US2023097985A1Nanoparticle formulations formed from histidine-lysine copolymersSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3455US2023257751A1METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST TGFB1 AND COX2SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 3555US2022333108A1Combinations of sirnas with sirnas against sulf2 or gpc3 for use in treating cancerSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3654US2026092275A1Products and compositionsSIRNAOMICS INC·Filed 2025·Application pending·0 cites
- 3753US2021162067A1Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid TherapeuticsSIRNAOMICS INC·Filed 2020·Application pending·0 cites
- 3853US2023233476A1Nanoparticle pharmaceutical compositions with reduced nanoparticle size and improved polydispersity indexSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 3952US2023121879A1Methods for preparing nanoparticle compositions containing histidine-lysine copolymersSIRNAOMICS INC·Filed 2022·Application pending·0 cites
- 4052US2022054645A1Targeted Delivery of Therapeutic MoleculesSIRNAOMICS INC·Filed 2021·Application pending·0 cites
- 4150US2018369273A1Pharmaceutical Composition and Applications ThereofSIRNAOMICS INC·Filed 2016·Application pending·0 cites
- 4247US9868952B2Compositions and methods for “resistance-proof” SiRNA therapeutics for influenzaSIRNAOMICS INC·Filed 2013·Granted Jan 16, 2018·0 cites·22 claims
- 4337US2017233742A1Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus DiseaseSIRNAOMICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIRNAOMICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →